BACKGROUND: Group 2 innate lymphoid cells (ILC2s) expand in the lungs of mice during type 2 inflammation induced by the fungal allergen Alternaria alternata. The increase in ILC2 numbers in the lung has been largely attributed to local proliferation and whether ILC2s migrate from the circulation to the lung after Alternaria exposure is unknown. OBJECTIVE: We examined whether human (lung, lymph node, and blood) and mouse lung ILC2s express β1 and β2 integrin adhesion molecules and whether these integrins are required for trafficking of ILC2s into the lungs of mice. METHODS: Human and mouse ILC2s were assessed for surface expression of β1 and β2 integrin adhesion molecules by using flow cytometry. The role of β1 and β2 integrins in ILC2 trafficking to the lungs was assessed by in vivo blocking of these integrins before airway exposure to Alternaria in mice. RESULTS: Both human and mouse lung ILC2s express high levels of β1 and β2 integrin adhesion receptors. Intranasal administration of Alternaria challenge reduced ILC2 numbers in the bone marrow and concurrently increased blood and lung ILC2 numbers. In vivo blocking of β2 integrins (CD18) significantly reduced ILC2 numbers in the lungs but did not alter ILC2 proliferation, apoptosis, and function. In contrast, in vivo blocking of β1 integrins or α4 integrins did not affect lung ILC2 numbers. CONCLUSION: ILC2 numbers increase in the mouse lung not only through local proliferation but also through trafficking from the circulation into the lung using β2 rather than β1 or α4 integrins.
BACKGROUND: Group 2 innate lymphoid cells (ILC2s) expand in the lungs of mice during type 2 inflammation induced by the fungal allergen Alternaria alternata. The increase in ILC2 numbers in the lung has been largely attributed to local proliferation and whether ILC2s migrate from the circulation to the lung after Alternaria exposure is unknown. OBJECTIVE: We examined whether human (lung, lymph node, and blood) and mouse lung ILC2s express β1 and β2 integrin adhesion molecules and whether these integrins are required for trafficking of ILC2s into the lungs of mice. METHODS:Human and mouse ILC2s were assessed for surface expression of β1 and β2 integrin adhesion molecules by using flow cytometry. The role of β1 and β2 integrins in ILC2 trafficking to the lungs was assessed by in vivo blocking of these integrins before airway exposure to Alternaria in mice. RESULTS: Both human and mouse lung ILC2s express high levels of β1 and β2 integrin adhesion receptors. Intranasal administration of Alternaria challenge reduced ILC2 numbers in the bone marrow and concurrently increased blood and lung ILC2 numbers. In vivo blocking of β2 integrins (CD18) significantly reduced ILC2 numbers in the lungs but did not alter ILC2 proliferation, apoptosis, and function. In contrast, in vivo blocking of β1 integrins or α4 integrins did not affect lung ILC2 numbers. CONCLUSION: ILC2 numbers increase in the mouse lung not only through local proliferation but also through trafficking from the circulation into the lung using β2 rather than β1 or α4 integrins.
Authors: Hannah H Walford; Sean J Lund; Rachel E Baum; Andrew A White; Christopher M Bergeron; Jacob Husseman; Kelly J Bethel; David R Scott; Naseem Khorram; Marina Miller; David H Broide; Taylor A Doherty Journal: Clin Immunol Date: 2014-09-16 Impact factor: 3.969
Authors: Hee-Kyoo Kim; Sean Lund; Rachel Baum; Peter Rosenthal; Naseem Khorram; Taylor A Doherty Journal: Int Arch Allergy Immunol Date: 2013-11-30 Impact factor: 2.749
Authors: E D Tait Wojno; L A Monticelli; S V Tran; T Alenghat; L C Osborne; J J Thome; C Willis; A Budelsky; D L Farber; D Artis Journal: Mucosal Immunol Date: 2015-04-08 Impact factor: 7.313
Authors: Franz Puttur; Laura Denney; Lisa G Gregory; Juho Vuononvirta; Robert Oliver; Lewis J Entwistle; Simone A Walker; Mark B Headley; Ewan J McGhee; James E Pease; Matthew F Krummel; Leo M Carlin; Clare M Lloyd Journal: Sci Immunol Date: 2019-06-07
Authors: Maya R Karta; Kellen Cavagnero; Marina Miller; Jana Badrani; Luay Naji; Taylor A Doherty; David H Broide Journal: J Allergy Clin Immunol Date: 2019-06-12 Impact factor: 10.793
Authors: Oyebola O Oyesola; Carolina Duque; Linda C Huang; Elisabeth M Larson; Simon P Früh; Lauren M Webb; Seth A Peng; Elia D Tait Wojno Journal: J Immunol Date: 2020-01-03 Impact factor: 5.422
Authors: Mahmoud Elashiry; Ranya Elsayed; Mohamed M Elashiry; Mohammad H Rashid; Roxan Ara; Ali S Arbab; Ahmed R Elawady; Mark Hamrick; Yutao Liu; Wenbo Zhi; Rudolf Lucas; Jose Vazquez; Christopher W Cutler Journal: Front Immunol Date: 2021-03-25 Impact factor: 7.561
Authors: Brennan J Blight; Amarbir S Gill; Jorgen S Sumsion; Chelsea E Pollard; Shaelene Ashby; Gretchen M Oakley; Jeremiah A Alt; Abigail Pulsipher Journal: J Asthma Allergy Date: 2021-05-27